Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE25.0600
- TODAY'S CHANGE (%)0.5900 (2.4111%)
- Bid / Lots24.8000/ 8
- Ask / Lots27.2200/ 1
- Open / Previous Close24.4900 / 24.4700
- Day Range
- 52 Week Range
- Volume829,868
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 13089 | 24.36 |
| 09:33 ET | 3968 | 24.095 |
| 09:35 ET | 1380 | 24.19 |
| 09:37 ET | 5521 | 24.375 |
| 09:39 ET | 1450 | 24.545 |
| 09:42 ET | 7125 | 24.1 |
| 09:44 ET | 1046 | 24.3 |
| 09:46 ET | 500 | 24.4 |
| 09:48 ET | 1275 | 24.7 |
| 09:50 ET | 2636 | 24.58 |
| 09:51 ET | 1235 | 24.505 |
| 09:53 ET | 200 | 24.485 |
| 09:55 ET | 1862 | 24.435 |
| 09:57 ET | 1508 | 24.45 |
| 10:00 ET | 1303 | 24.43 |
| 10:02 ET | 1146 | 24.4 |
| 10:04 ET | 400 | 24.38 |
| 10:06 ET | 1709 | 24.27 |
| 10:08 ET | 380 | 24.21 |
| 10:09 ET | 709 | 24.2557 |
| 10:11 ET | 1000 | 24.35 |
| 10:13 ET | 1282 | 24.23 |
| 10:15 ET | 1223 | 24.26 |
| 10:18 ET | 1818 | 24.2 |
| 10:20 ET | 900 | 24.21 |
| 10:22 ET | 700 | 24.23 |
| 10:24 ET | 2656 | 24.14 |
| 10:26 ET | 1907 | 24.025 |
| 10:27 ET | 707 | 24.09 |
| 10:29 ET | 766 | 24.04 |
| 10:31 ET | 900 | 24.02 |
| 10:33 ET | 500 | 24.08 |
| 10:36 ET | 550 | 24.035 |
| 10:38 ET | 1100 | 24.05 |
| 10:40 ET | 1575 | 24.07 |
| 10:42 ET | 500 | 23.875 |
| 10:44 ET | 3591 | 23.97 |
| 10:45 ET | 6580 | 24.025 |
| 10:47 ET | 721 | 24 |
| 10:49 ET | 2598 | 24.33 |
| 10:51 ET | 10700 | 24.5 |
| 10:54 ET | 500 | 24.545 |
| 10:56 ET | 7982 | 24.48 |
| 10:58 ET | 400 | 24.49 |
| 11:00 ET | 900 | 24.57 |
| 11:02 ET | 4424 | 24.57 |
| 11:03 ET | 2620 | 24.69 |
| 11:05 ET | 9858 | 24.76 |
| 11:07 ET | 794 | 24.74 |
| 11:09 ET | 718 | 24.77 |
| 11:12 ET | 800 | 24.81 |
| 11:14 ET | 300 | 24.79 |
| 11:16 ET | 600 | 24.86 |
| 11:18 ET | 780 | 24.8587 |
| 11:20 ET | 200 | 24.87 |
| 11:21 ET | 1000 | 24.8 |
| 11:23 ET | 899 | 24.78 |
| 11:25 ET | 200 | 24.75 |
| 11:27 ET | 500 | 24.71 |
| 11:30 ET | 900 | 24.72 |
| 11:32 ET | 500 | 24.74 |
| 11:34 ET | 971 | 24.71 |
| 11:38 ET | 100 | 24.725 |
| 11:39 ET | 500 | 24.76 |
| 11:41 ET | 1697 | 24.83 |
| 11:43 ET | 700 | 24.88 |
| 11:45 ET | 200 | 24.82 |
| 11:48 ET | 544 | 24.84 |
| 11:50 ET | 3055 | 24.78 |
| 11:52 ET | 700 | 24.81 |
| 11:54 ET | 600 | 24.77 |
| 11:56 ET | 300 | 24.73 |
| 11:57 ET | 200 | 24.71 |
| 11:59 ET | 605 | 24.72 |
| 12:01 ET | 1040 | 24.74 |
| 12:06 ET | 100 | 24.7 |
| 12:08 ET | 1200 | 24.75 |
| 12:12 ET | 2640 | 24.77 |
| 12:14 ET | 300 | 24.74 |
| 12:15 ET | 1100 | 24.79 |
| 12:19 ET | 500 | 24.76 |
| 12:21 ET | 600 | 24.8 |
| 12:24 ET | 1401 | 24.89 |
| 12:26 ET | 300 | 24.905 |
| 12:28 ET | 100 | 24.93 |
| 12:30 ET | 5289 | 24.88 |
| 12:32 ET | 700 | 24.875 |
| 12:37 ET | 283 | 24.885 |
| 12:39 ET | 2600 | 24.88 |
| 12:42 ET | 2406 | 24.875 |
| 12:44 ET | 200 | 24.84 |
| 12:46 ET | 1504 | 24.81 |
| 12:48 ET | 100 | 24.86 |
| 12:50 ET | 1400 | 24.85 |
| 12:51 ET | 1718 | 24.87 |
| 12:53 ET | 2185 | 24.97 |
| 12:55 ET | 547 | 25.005 |
| 12:57 ET | 860 | 24.99 |
| 01:00 ET | 300 | 25.01 |
| 01:02 ET | 200 | 24.985 |
| 01:04 ET | 1386 | 24.88 |
| 01:09 ET | 1348 | 24.825 |
| 01:11 ET | 253 | 24.815 |
| 01:13 ET | 3277 | 24.75 |
| 01:15 ET | 1261 | 24.79 |
| 01:18 ET | 700 | 24.81 |
| 01:20 ET | 5353 | 24.72 |
| 01:22 ET | 17464 | 24.79 |
| 01:24 ET | 300 | 24.82 |
| 01:26 ET | 100 | 24.83 |
| 01:27 ET | 1473 | 24.83 |
| 01:29 ET | 565 | 24.81 |
| 01:31 ET | 436 | 24.81 |
| 01:36 ET | 200 | 24.835 |
| 01:38 ET | 2586 | 24.84 |
| 01:42 ET | 793 | 24.8 |
| 01:44 ET | 200 | 24.77 |
| 01:45 ET | 500 | 24.785 |
| 01:49 ET | 1180 | 24.72 |
| 01:54 ET | 208 | 24.71 |
| 02:00 ET | 1736 | 24.605 |
| 02:02 ET | 1098 | 24.61 |
| 02:03 ET | 48460 | 24.71 |
| 02:05 ET | 26262 | 24.64 |
| 02:07 ET | 100 | 24.65 |
| 02:09 ET | 4873 | 24.6 |
| 02:12 ET | 1774 | 24.52 |
| 02:14 ET | 600 | 24.47 |
| 02:16 ET | 300 | 24.425 |
| 02:18 ET | 540 | 24.415 |
| 02:20 ET | 900 | 24.43 |
| 02:21 ET | 300 | 24.43 |
| 02:23 ET | 900 | 24.43 |
| 02:25 ET | 1738 | 24.46 |
| 02:27 ET | 100 | 24.48 |
| 02:30 ET | 891 | 24.49 |
| 02:32 ET | 600 | 24.45 |
| 02:34 ET | 1000 | 24.51 |
| 02:36 ET | 565 | 24.49 |
| 02:38 ET | 200 | 24.46 |
| 02:39 ET | 300 | 24.4909 |
| 02:41 ET | 1250 | 24.39 |
| 02:43 ET | 500 | 24.385 |
| 02:45 ET | 500 | 24.38 |
| 02:48 ET | 1200 | 24.38 |
| 02:50 ET | 426 | 24.35 |
| 02:52 ET | 400 | 24.3 |
| 02:54 ET | 2203 | 24.35 |
| 02:56 ET | 1010 | 24.395 |
| 02:57 ET | 1100 | 24.45 |
| 02:59 ET | 100 | 24.47 |
| 03:01 ET | 600 | 24.465 |
| 03:03 ET | 801 | 24.595 |
| 03:06 ET | 4382 | 24.57 |
| 03:08 ET | 462 | 24.57 |
| 03:10 ET | 100 | 24.595 |
| 03:12 ET | 100 | 24.61 |
| 03:14 ET | 700 | 24.57 |
| 03:15 ET | 900 | 24.61 |
| 03:17 ET | 3318 | 24.7 |
| 03:19 ET | 4537 | 24.86 |
| 03:21 ET | 2100 | 24.96 |
| 03:24 ET | 1900 | 25.04 |
| 03:26 ET | 2294 | 25.06 |
| 03:28 ET | 3162 | 25.17 |
| 03:30 ET | 3624 | 25.11 |
| 03:32 ET | 826 | 24.94 |
| 03:33 ET | 3042 | 24.98 |
| 03:35 ET | 1224 | 24.99 |
| 03:37 ET | 1209 | 24.93 |
| 03:39 ET | 811 | 24.83 |
| 03:42 ET | 5720 | 24.99 |
| 03:44 ET | 1699 | 25.07 |
| 03:46 ET | 300 | 25.035 |
| 03:48 ET | 27014 | 25.05 |
| 03:50 ET | 2786 | 25.15 |
| 03:51 ET | 7068 | 25.2 |
| 03:53 ET | 8245 | 25.16 |
| 03:55 ET | 9010 | 25.17 |
| 03:57 ET | 12986 | 25.045 |
| 04:00 ET | 162710 | 25.06 |
Oct 31, 2024
Nurix Therapeutics to Participate in Upcoming Investor Conferences, from 7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 24, 2024
DJ Nurix Therapeutics Initiated at Buy by UBS, from 7:55AM ET on Thursday Oct 24, 2024 by Dow Jones
7:55AM ET on Thursday Oct 24, 2024 by Dow Jones
Oct 21, 2024
Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit, from 4:00PM ET on Monday Oct 21, 2024 by Dow Jones
4:00PM ET on Monday Oct 21, 2024 by Dow JonesDJ Nurix Therapeutics Price Target Maintained With a $29.00/Share by Needham, from 7:25AM ET on Monday Oct 21, 2024 by Dow Jones
7:25AM ET on Monday Oct 21, 2024 by Dow JonesDJ Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 7:15AM ET on Monday Oct 21, 2024 by Dow Jones
7:15AM ET on Monday Oct 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.7B | -8.6x | --- |
Arvinas Inc | 1.8B | -5.6x | --- |
Recursion Pharmaceuticals Inc | 1.9B | -4.1x | --- |
Tarsus Pharmaceuticals Inc | 1.8B | -10.4x | --- |
Immatics NV | 1.3B | -10.4x | --- |
Celldex Therapeutics Inc | 1.7B | -9.3x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
|---|---|
Revenue (TTM) | $56.4M |
Shares Outstanding | 70.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.20 |
EPS | $-2.91 |
Book Value | $4.12 |
P/E Ratio | -8.6x |
Price/Sales (TTM) | 30.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -343.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
